Lumexa Imaging Q4 Revenue $267.73M Beats Expectations
Reports Q4 revenue $267.73M, consensus $261.8M. Same center advanced volume growth: 12.7% for consolidated and 9.2% for system-wide. "The fourth quarter of 2025 marked a strong close to an important year for Lumexa Imaging, with continued momentum across the business," said Caitlin Zulla, CEO of Lumexa Imaging. "Strong Adjusted EBITDA growth was driven by advanced imaging volumes, ramping new de novo centers, and our return in-network with a large payer in New Jersey. We strengthened our balance sheet, reducing leverage by two turns, and opened a record number of de novo centers during the year, setting the stage for future growth."
